CP26
Anti-Integrin β₁ Mouse mAb (4B7)
liquid, clone 4B7, Calbiochem®
Faça loginpara ver os preços organizacionais e de contrato
About This Item
Código UNSPSC:
12352203
fonte biológica
mouse
Nível de qualidade
tipo de produto de anticorpo
primary antibodies
clone
4B7, monoclonal
Formulário
liquid
não contém
preservative
reatividade de espécies
human
não deve reagir com
mouse, rat
fabricante/nome comercial
Calbiochem®
condição de armazenamento
OK to freeze
avoid repeated freeze/thaw cycles
desiccated
Isotipo
IgG1
Condições de expedição
wet ice
temperatura de armazenamento
−20°C
Descrição geral
Purified mouse monoclonal antibody generated by immunizing mice with the specified immunogen and fusing splenocytes with Sp2/0 mouse myeloma cells. Recognizes the β1 integrin subunit.
Recognizes the β1 integrin subunit in A431 and Jurkat cells.
Imunogênio
Human
recombinant, human β1 integrin
Aplicação
Frozen Sections (2 µg/ml)
Immunofluorescence (2.5 µg/ml)
Immunoprecipitation (1 µg/sample)
Paraffin Sections (2 µg/ml, no pre-treatment required)
Immunoblotting (not recommended)
Neutralization Studies (see application references)
Immunofluorescence (2.5 µg/ml)
Immunoprecipitation (1 µg/sample)
Paraffin Sections (2 µg/ml, no pre-treatment required)
Immunoblotting (not recommended)
Neutralization Studies (see application references)
Embalagem
Please refer to vial label for lot-specific concentration.
Advertência
Toxicity: Standard Handling (A)
forma física
In 50 mM sodium phosphate buffer, 50% glycerol.
Reconstituição
Following initial thaw, aliquot and freeze (-20°C).
Nota de análise
Positive Control
A-431 or Jurkat cells or skin tissue
A-431 or Jurkat cells or skin tissue
Outras notas
Akiyama, S.K. 1996. Hum. Cell.9, 181.
Farnoud, M.R. et al. 1996. Int. J. Cancer67, 45.
Morimoto, C. and Tachibana, K. 1996. Hum. Cell.9, 163.
Webb, D.L. et al. 1996. J. Cell. Biochem.61, 127.
Schaller, M.D. et al. 1995. J. Cell. Biol.130, 1181.
Akiyama, S.K. et al. 1994. J. Biol. Chem.269, 15961.
Albelda, S.M. 1993. Lab. Invest.68, 4.
Evans, C.W. 1992. Cell. Biol. Int. Rep.16, 1.
Albelds, S.M. and Buck, C.A. 1990. FASEB J.4, 2868.
Farnoud, M.R. et al. 1996. Int. J. Cancer67, 45.
Morimoto, C. and Tachibana, K. 1996. Hum. Cell.9, 163.
Webb, D.L. et al. 1996. J. Cell. Biochem.61, 127.
Schaller, M.D. et al. 1995. J. Cell. Biol.130, 1181.
Akiyama, S.K. et al. 1994. J. Biol. Chem.269, 15961.
Albelda, S.M. 1993. Lab. Invest.68, 4.
Evans, C.W. 1992. Cell. Biol. Int. Rep.16, 1.
Albelds, S.M. and Buck, C.A. 1990. FASEB J.4, 2868.
Antibody should be titrated for optimal results in individual systems.
Informações legais
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
Não está encontrando o produto certo?
Experimente o nosso Ferramenta de seleção de produtos.
Código de classe de armazenamento
10-13 - German Storage Class 10 to 13
Certificados de análise (COA)
Busque Certificados de análise (COA) digitando o Número do Lote do produto. Os números de lote e remessa podem ser encontrados no rótulo de um produto após a palavra “Lot” ou “Batch”.
Já possui este produto?
Encontre a documentação dos produtos que você adquiriu recentemente na biblioteca de documentos.
Yang-Er Chen et al.
Scientific reports, 7(1), 12718-12718 (2017-10-07)
Reversible phosphorylation of proteins and the assembly of thylakoid complexes are the important protective mechanism against environmental stresses in plants. This research was aimed to investigate the different responses of the antioxidant defense system and photosystem II (PSII) to osmotic
Ana Carreras-González et al.
PLoS pathogens, 15(11), e1008163-e1008163 (2019-11-19)
Macrophages mediate the elimination of pathogens by phagocytosis resulting in the activation of specific signaling pathways that lead to the production of cytokines, chemokines and other factors. Borrelia burgdorferi, the causative agent of Lyme disease, causes a wide variety of
Anna L Guildford et al.
Journal of the Royal Society, Interface, 8(58), 641-649 (2010-11-26)
In-stent restenosis is a clinical complication following coronary angioplasty caused by the implantation of the metal device in the atherosclerotic vessel. Histological examination has shown a clear contribution of both inflammatory and smooth muscle cells (SMCs) to the deposition of
Nossa equipe de cientistas tem experiência em todas as áreas de pesquisa, incluindo Life Sciences, ciência de materiais, síntese química, cromatografia, química analítica e muitas outras.
Entre em contato com a assistência técnica